Bank of America’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIV
NMC
MAM
RG
USAA
BCM
Bank of America's TRIV Position: Q3 2015 in Review
Bank of America sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q3 2015, closing a stake of 178 shares — an estimated $1K sold.
Bank of America first reported a position in TRIV in Q2 2014 and held it in 5 quarters. The position peaked at $50K in Q2 2014. 26 funds tracked by Wall St. Rank hold TRIV as of Q3 2015.
- Bank of America reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q3 2015 after selling out during the quarter.
- Bank of America sold 178 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q3 2015, an estimated $1K.
- Bank of America first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 5 quarters.
- Bank of America's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $50K in Q2 2014.
- 26 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q3 2015.
Based on Bank of America's 13F filing for Q3 2015, filed 16 Nov 2015.